Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EyeCRO specializes in providing comprehensive preclinical research services for ophthalmic drugs and devices. The company offers efficacy, pharmacokinetics, toxicology, and formulation development using well-established animal models. Their proprietary MiDROPS® technology enables novel eyedrop formulations of lipophilic small molecules with improved ocular penetration. They have contributed to validation work on gene therapies such as LUXTURNA®. No direct clinical results or internal therapeutic programs are reported since they operate as a service provider.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EyeCRO.